Palo Alto Investors »

Alnylam Pharmaceuticals shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 141k 275.03
2024-03-31 $27M 183k 149.45
2023-12-31 $30M 154k 191.41